calendar
6,644 catalysts · 3,685 8k filing · 1,000 device adverse event · 775 grant · 578 earnings · 234 approval · 172 phase 2 completion
6,644 catalysts · 3,685 8k filing · 1,000 device adverse event · 775 grant · 578 earnings · 234 approval · 172 phase 2 completion
Items: 1.01, 9.01
Items: 8.01, 9.01
Items: 7.01, 9.01
Items: 8.01, 9.01
Items: 8.01, 9.01
Items: 8.01, 9.01
Items: 7.01, 8.01, 9.01
Items: 1.01, 2.03, 3.02, 8.01, 9.01
Items: 8.01
Items: 3.01, 8.01
Items: 5.02
This page contains notices of advisory committee meetings. Refer to the individual meeting link below for more information on the anticipated format of each meeting. For previous years' advisory committee calendars, see the FDA Archive.
Items: 1.01, 8.01, 9.01
Items: 7.01, 9.01
Items: 1.02
Items: 2.05, 3.01, 5.02, 7.01, 8.01, 9.01
Items: 5.02
Items: 8.01
Items: 8.01, 9.01
Items: 2.02, 9.01
Items: 1.01
Items: 2.02, 9.01
Items: 5.02
Items: 8.01
Items: 9.01
Items: 8.01, 9.01
Items: 1.01, 3.01
Items: 1.01, 3.02, 7.01, 9.01
Items: 1.01, 3.03, 5.03, 7.01, 9.01
Items: 1.01, 2.03, 3.02, 9.01
Items: 8.01, 9.01
Items: 1.01, 3.02, 9.01
Items: 5.02, 7.01, 9.01
Items: 5.03, 9.01
Items: 8.01, 9.01
Items: 5.02, 7.01, 9.01
Items: 7.01, 9.01
Items: 8.01, 9.01
Items: 1.01, 9.01
Items: 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
Items: 7.01, 9.01
Items: 8.01, 9.01
action date of January 4, 2027
action date of Jan. 21, 2027